title: Effect of adjuvant formulations on the selection of B-cell epitopes expressed by a malaria peptide vaccine.
abstract: Because subunit vaccines may create artificial epitopes, the goal of this study was to concentrate the immune response toward protective epitopes contained in a peptide, [(NAGG)5]Y. This peptide consisted of five repeat sequences of the immunodominant epitope of the circumsporozoite protein of the simian malaria parasite Plasmodium cynomolgi and a terminal tyrosine. It was conjugated to bovine serum albumin and mixed with various adjuvant formulations, including block copolymers L121, L141, L180.5 and a lipopolysaccharide (LPS). Outbred mice were vaccinated with seven vaccine formulations. Postvaccination sera from each group of mice were then pooled, and antibody responses against peptide [(NAGG)5]Y or (NAGG)5 were tested in an enzyme-linked immunosorbent assay and against sporozoites of P. cynomolgi in an indirect fluorescent antibody assay. Although all groups elicited a high antibody response to the peptide [(NAGG)5Y], the presence of the tyrosine induced a different antibody response to the peptide (NAGG)5, and formulations containing LPS alone did not induce an antibody response to either (NAGG)5 or P. cynomolgi sporozoites. The formulation including both LPS and the copolymer L121 was the only one to inhibit the development of P. cynomolgi sporozoites in rhesus monkey hepatocytes by 50%. These results suggest that vaccine formulations influence B-cell epitope selection.
authors.affiliation: Malaria Branch, Division of Parasitic Diseases, Centers for Disease Control, Atlanta, GA 30333.
authors.forename: P
authors.initials: P
authors.lastname: Millet
authors.forename: M L
authors.initials: ML
authors.lastname: Kalish
authors.forename: W E
authors.initials: WE
authors.lastname: Collins
authors.forename: R L
authors.initials: RL
authors.lastname: Hunter
mesh_terms: D000818:Animals; D000913:Antibodies, Protozoan / Q000032:analysis; D001402:B-Lymphocytes / Q000276:immunology*; D000939:Epitopes / Q000032:analysis*; D005260:Female; D051379:Mice; D010446:Peptide Fragments / Q000008:administration & dosage* / Q000276:immunology; D016789:Plasmodium cynomolgi / Q000276:immunology*; D016052:Protozoan Vaccines / Q000008:administration & dosage* / Q000276:immunology; D014611:Vaccination
chemical_list: D000913:Antibodies, Protozoan; D000939:Epitopes; D010446:Peptide Fragments; D016052:Protozoan Vaccines